Investigation into proposed mergers and sales for shareholders of TURN, HLGN, CARM, and GNTY.

Monteverde & Associates PC is investigating several mergers and acquisitions, including 180 Degree Capital Corp.'s proposed merger with Mount Logan Capital Inc., Heliogen's sale to Zeo Energy Corp., Carisma Therapeutics' sale to OrthoCellix, and Guaranty Bancshares' sale to Glacier Bancorp. The firm is seeking to recover losses for shareholders and has a successful track record in trial and appellate courts. Shareholders are encouraged to contact Monteverde & Associates PC for more information.

Monteverde & Associates PC, a prominent class action securities firm, is currently investigating several high-profile mergers and acquisitions (M&A) that could potentially impact shareholders. The firm, recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report, is known for its successful track record in recovering millions of dollars for shareholders [1].

One of the key investigations involves 180 Degree Capital Corp.'s (NASDAQ:TURN) proposed merger with Mount Logan Capital Inc. (the "Business Combination"). The preliminary net asset value (NAV) per share of 180 Degree Capital as of June 30, 2025, stood at $4.80, an increase of approximately 8.6% from the prior quarter and 3.4% year-to-date [3]. The firm has also noted the filing of an updated preliminary joint proxy statement/prospectus with the Securities and Exchange Commission (SEC) regarding the proposed merger [3].

Additionally, Monteverde & Associates PC is investigating Heliogen's (OTC:HLGN) sale to Zeo Energy Corp. (OTC:ZEO). Details of the sale, including the terms and potential impacts on shareholders, are currently under review by the firm. Similarly, Carisma Therapeutics' (NASDAQ:CRM) sale to OrthoCellix and Guaranty Bancshares' (NASDAQ:GBAN) sale to Glacier Bancorp are also being scrutinized for potential shareholder losses [2].

The firm's investigations aim to recover losses for shareholders who may have been negatively impacted by these transactions. Monteverde & Associates PC encourages shareholders to contact them for more information and to discuss their concerns. The firm's offices are located at the Empire State Building in New York City, and shareholders can reach out to Juan Monteverde, Esq., either via email at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341 [1][2].

References:
[1] https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-investigates-the-merger-hson-enzb-and-brzh-302503586.html
[2] https://www.globenewswire.com/news-release/2025/07/09/3112797/0/en/HAREHOLDER-ALERT-Class-Action-Attorney-Juan-Monteverde-Investigates-the-Merger-of-CARGO-Therapeutics-Inc-NASDAQ-CRGX.html
[3] https://finance.yahoo.com/news/180-degree-capital-corp-notes-120000319.html